47
48 17. Clements PM, Breslin C, Deeks ED, et al. The ataxia-oculomotor apraxia 1 gene product
has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4. DNA Repair (Amst) 2004;3(11):1493-502. DOI:
10.1016/j.dnarep.2004.06.017.
18. Zheng J, Croteau DL, Bohr VA, Akbari M. Diminished OPA1 expression and impaired mitochondrial morphology and homeostasis in Aprataxin-deficient cells. Nucleic Acids Res 2019;47(8):4086-4110. DOI: 10.1093/nar/gkz083.
19. Renaud M, Moreira MC, Ben Monga B, et al. Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1. JAMA Neurol 2018;75(4):495-502. DOI:
10.1001/jamaneurol.2017.4373.
20. Criscuolo C, Mancini P, Menchise V, et al. Very late onset in ataxia oculomotor apraxia type I. Ann Neurol 2005;57(5):777. DOI: 10.1002/ana.20463.
21. Le Ber I, Moreira MC, Rivaud-Pechoux S, et al. Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 2003;126(Pt 12):2761-72. DOI:
10.1093/brain/awg283.
22. Moreira MC, Barbot C, Tachi N, et al. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet 2001;29(2):189-93. DOI:
10.1038/ng1001-189.
23. Barbot C, Coutinho P, Chorao R, et al. Recessive ataxia with ocular apraxia: review of 22 Portuguese patients. Arch Neurol 2001;58(2):201-5. DOI:
10.1001/archneur.58.2.201.
24. Amouri R, Moreira MC, Zouari M, et al. Aprataxin gene mutations in Tunisian families.
Neurology 2004;63(5):928-9. DOI: 10.1212/01.wnl.0000137044.06573.46.
25. Duncan EJ, Lariviere R, Bradshaw TY, et al. Altered organization of the intermediate filament cytoskeleton and relocalization of proteostasis modulators in cells lacking the ataxia protein sacsin. Hum Mol Genet 2017;26(16):3130-3143. DOI:
10.1093/hmg/ddx197.
26. Girard M, Lariviere R, Parfitt DA, et al. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). Proc Natl Acad Sci U S A 2012;109(5):1661-6. DOI: 10.1073/pnas.1113166109.
27. Pilliod J, Moutton S, Lavie J, et al. New practical definitions for the diagnosis of autosomal recessive spastic ataxia of Charlevoix-Saguenay. Ann Neurol 2015;78(6):871-86. DOI: 10.1002/ana.24509.
28. Gomez CM. ARSACS goes global. Neurology 2004;62(1):10-1. DOI:
10.1212/wnl.62.1.10.
29. Kuchay RAH, Mir YR, Zeng X, et al. ARSACS as a Worldwide Disease: Novel SACS Mutations Identified in a Consanguineous Family from the Remote Tribal Jammu and Kashmir Region in India. Cerebellum 2019;18(4):807-812. DOI: 10.1007/s12311-019-01028-2.
30. Baets J, Deconinck T, Smets K, et al. Mutations in SACS cause atypical and late-onset forms of ARSACS. Neurology 2010;75(13):1181-8. DOI:
10.1212/WNL.0b013e3181f4d86c.
49 31. Vermeer S, Meijer RP, Pijl BJ, et al. ARSACS in the Dutch population: a frequent cause
of early-onset cerebellar ataxia. Neurogenetics 2008;9(3):207-14. DOI:
10.1007/s10048-008-0131-7.
32. Blumkin L, Bradshaw T, Michelson M, et al. Molecular and functional studies of retinal degeneration as a clinical presentation of SACS-related disorder. Eur J Paediatr Neurol 2015;19(4):472-6. DOI: 10.1016/j.ejpn.2015.02.005.
33. Xiromerisiou G, Dadouli K, Marogianni C, et al. A novel homozygous SACS mutation identified by whole exome sequencing-genotype phenotype correlations of all
published cases. J Mol Neurosci 2020;70(1):131-141. DOI: 10.1007/s12031-019-01410-z.
34. Rezende Filho FM, Parkinson MH, Pedroso JL, et al. Clinical, ophthalmological, imaging and genetic features in Brazilian patients with ARSACS. Parkinsonism Relat Disord 2019;62:148-155. DOI: 10.1016/j.parkreldis.2018.12.024.
35. Sanchez MG, Perez JE, Perez MR, Redondo AG. Novel SACS mutation in autosomal recessive spastic ataxia of Charlevoix-Saguenay. J Neurol Sci 2015;358(1-2):475-6. DOI:
10.1016/j.jns.2015.08.032.
36. Sahin T, Karaarslan FT, Yilmaz R, Tekgul S, Basak AN, Akbostanci MC. Two cases of early-onset autosomal recessive spastic ataxia of Charlevoix-Saguenay diagnosed in adulthood. Clin Neurol Neurosurg 2021;201:106423. DOI:
10.1016/j.clineuro.2020.106423.
37. Nagappa M, Bindu PS, Sinha S, Mathuranath PS, Taly AB. Exome sequencing in adult neurology practice: Challenges and rewards in a mixed resource setting. Clin Neurol Neurosurg 2018;174:48-56. DOI: 10.1016/j.clineuro.2018.09.012.
38. Hannah-Shmouni F, Al-Shahoumi R, Brady LI, Wu L, Frei J, Tarnopolsky MA. Dual molecular diagnoses in a neurometabolic specialty clinic. Am J Med Genet A 2021;185(3):766-773. DOI: 10.1002/ajmg.a.62034.
39. Hata Y, Oku Y, Taneichi H, et al. Two autopsy cases of sudden unexpected death from Dravet syndrome with novel de novo SCN1A variants. Brain Dev 2020;42(2):171-178.
DOI: 10.1016/j.braindev.2019.10.005.
40. Wayhelova M, Ryzi M, Oppelt J, et al. Novel familial IQSEC2 pathogenic sequence variant associated with neurodevelopmental disorders and epilepsy. Neurogenetics 2020;21(4):269-278. DOI: 10.1007/s10048-020-00616-3.
41. Wiedemann A, Chery C, Coelho D, et al. Mutations in MTHFR and POLG impaired activity of the mitochondrial respiratory chain in 46-year-old twins with spastic paraparesis. J Hum Genet 2020;65(2):91-98. DOI: 10.1038/s10038-019-0689-y.
42. Marttila M, Win W, Al-Ghamdi F, Abdel-Hamid HZ, Lacomis D, Beggs AH. MYL2-associated congenital fiber-type disproportion and cardiomyopathy with variants in additional neuromuscular disease genes; the dilemma of panel testing. Cold Spring Harb Mol Case Stud 2019;5(4). DOI: 10.1101/mcs.a004184.
43. Dangiolo SB, Wilson A, Jobanputra V, Anyane-Yeboa K. Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome. Am J Med Genet A 2015;167A(12):3161-6. DOI:
10.1002/ajmg.a.37342.
44. Moteki H, Azaiez H, Booth KT, et al. Hearing loss caused by a P2RX2 mutation identified in a MELAS family with a coexisting mitochondrial 3243AG mutation. Ann Otol Rhinol Laryngol 2015;124 Suppl 1:177S-83S. DOI: 10.1177/0003489415575045.
50 45. Nectoux J, de Cid R, Baulande S, et al. Detection of TRIM32 deletions in LGMD patients
analyzed by a combined strategy of CGH array and massively parallel sequencing. Eur J Hum Genet 2015;23(7):929-34. DOI: 10.1038/ejhg.2014.223.
46. Li L, Zhao JQ, Wang C, et al. Whole-exome sequencing as a powerful tool for identifying genetic causes in a patient with POLG-related disorders and phenylketonuria. J Int Med Res 2019;47(3):1387-1394. DOI:
10.1177/0300060518823096.
47. Lal D, Neubauer BA, Toliat MR, et al. Increased Probability of Co-Occurrence of Two Rare Diseases in Consanguineous Families and Resolution of a Complex Phenotype by Next Generation Sequencing. PLoS One 2016;11(1):e0146040. DOI:
10.1371/journal.pone.0146040.
48. Cordova-Fletes C, Becerra-Solano LE, Rangel-Sosa MM, et al. Uncommon runs of homozygosity disclose homozygous missense mutations in two ciliopathy-related genes (SPAG17 and WDR35) in a patient with multiple brain and skeletal anomalies.
Eur J Med Genet 2018;61(3):161-167. DOI: 10.1016/j.ejmg.2017.11.011.
49. Klimkowicz-Mrowiec A, Dziubek A, Sado M, Karpinski M, Gorzkowska A. The Utility of Next-Generation Sequencing for Identifying the Genetic Basis of Dementia. Int J Environ Res Public Health 2021;18(16). DOI: 10.3390/ijerph18168520.
50. Manzanilla-Romero HH, Weis D, Schnaiter S, Rudnik-Schoneborn S. Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: Comparison of clinical characteristics and diagnostic pathways. Am J Med Genet A
2021;185(12):3851-3858. DOI: 10.1002/ajmg.a.62433.
51. Fabrizi GM, Hoyer H, Taioli F, et al. Inherited motor-sensory neuropathy with upper limb predominance associated with the tropomyosin-receptor kinase fused gene.
Neuromuscul Disord 2020;30(3):227-231. DOI: 10.1016/j.nmd.2019.12.007.
52. Melchionda L, Fang M, Wang H, et al. Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant. Orphanet J Rare Dis 2013;8:66. DOI: 10.1186/1750-1172-8-66.
53. Maselli RA, Arredondo J, Nguyen J, et al. Exome sequencing detection of two untranslated GFPT1 mutations in a family with limb-girdle myasthenia. Clin Genet 2014;85(2):166-71. DOI: 10.1111/cge.12118.
54. Delmiro A, Rivera H, Garcia-Silva MT, et al. Whole-exome sequencing identifies a variant of the mitochondrial MT-ND1 gene associated with epileptic encephalopathy:
west syndrome evolving to Lennox-Gastaut syndrome. Hum Mutat 2013;34(12):1623-7. DOI: 10.1002/humu.22445.
55. Coussa RG, Otto EA, Gee HY, et al. WDR19: an ancient, retrograde, intraflagellar ciliary protein is mutated in autosomal recessive retinitis pigmentosa and in Senior-Loken syndrome. Clin Genet 2013;84(2):150-9. DOI: 10.1111/cge.12196.
56. Armour CM, Smith A, Hartley T, et al. Syndrome disintegration: Exome sequencing reveals that Fitzsimmons syndrome is a co-occurrence of multiple events. Am J Med Genet A 2016;170(7):1820-5. DOI: 10.1002/ajmg.a.37684.
57. Vargas Lebron C, Ruiz Montesino MD, Moreira Navarrete V, Arostegui Gorospe JI.
Trichorhinophalangeal syndrome. Reumatol Clin (Engl Ed) 2020;16(6):499-501. DOI:
10.1016/j.reuma.2018.08.015.
51 58. Marchese M, Valvo G, Moro F, Sicca F, Santorelli FM. Targeted Gene Resequencing
(Astrochip) to Explore the Tripartite Synapse in Autism-Epilepsy Phenotype with Macrocephaly. Neuromolecular Med 2016;18(1):69-80. DOI: 10.1007/s12017-015-8378-2.
59. Azakli H, Gurses C, Arikan M, et al. Whole mitochondrial DNA variations in
hippocampal surgical specimens and blood samples with high-throughput sequencing:
a case of mesial temporal lobe epilepsy with hippocampal sclerosis. Gene 2013;529(1):190-4. DOI: 10.1016/j.gene.2013.06.077.
60. Chakrabarty S, Savantre SB, Ramachandra Bhat C, Satyamoorthy K. Multiple genetic mutations implicate spectrum of phenotypes in Bardet-Biedl syndrome. Gene 2020;725:144164. DOI: 10.1016/j.gene.2019.144164.
61. Beigi F, Del Pozo-Valero M, Martin-Merida I, et al. Apparent but unconfirmed digenism in an Iranian consanguineous family with syndromic Retinal Disease. Exp Eye Res 2021;207:108533. DOI: 10.1016/j.exer.2021.108533.
62. Uittenbogaard M, Wang H, Zhang VW, et al. The nuclear background influences the penetrance of the near-homoplasmic m.1630 A>G MELAS variant in a symptomatic proband and asymptomatic mother. Mol Genet Metab 2019;126(4):429-438. DOI:
10.1016/j.ymgme.2019.01.022.
63. Tsurusaki Y, Okamoto N, Suzuki Y, et al. Exome sequencing of two patients in a family with atypical X-linked leukodystrophy. Clin Genet 2011;80(2):161-6. DOI:
10.1111/j.1399-0004.2011.01721.x.